Pancreatic Cancer Research

ResearcherUniversity of BirminghamActive in the last 2 years

James Michael Halle-Smith

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6241-5680; OpenAlex author ID A5005520935. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 4 papers · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. Co-author DOI 10.3390/jcm15093225↗
  2. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … First author DOI 10.1097/sla.0000000000006272↗
  3. Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2024.09.002↗
  4. Effect of peri-adventitial superior mesenteric artery dissection on margin status during pancreaticoduodenectomy for resectable pancreatic cancer: the DISSECT … Co-author DOI 10.1093/bjsopen/zrae075↗
  5. The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Co-author DOI 10.1097/js9.0000000000001762↗
  6. Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16050996↗
  7. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2↗
  8. Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients. Co-author DOI 10.3390/cancers15092466↗
  9. Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies? Co-author DOI 10.3390/cancers15215140↗
  10. Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review. Co-author DOI 10.4240/wjgs.v15.i7.1512↗
  11. Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.ejso.2021.04.031↗
  12. Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. Co-author DOI 10.1016/j.hpb.2021.03.003↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keith John Roberts · 10 shared papers, 2021–2026 · strength 1.98
  2. Lewis A Hall · 6 shared papers, 2021–2026 · strength 1.25
  3. Sarah F. Powell-Brett · 5 shared papers, 2023–2024 · strength 1.10
  4. Nikolaos A. Chatzizacharias · 3 shared papers, 2023–2024 · strength 0.70
  5. Shivan Sivakumar · 2 shared papers, 2024–2026 · strength 0.47
  6. Adam Enver Frampton · 3 shared papers, 2021–2024 · strength 0.44
  7. Paul A. H. Moss · 2 shared papers, 2023–2024 · strength 0.41
  8. Nabeel Merali · 2 shared papers, 2023–2024 · strength 0.36
  9. Charlotte Terry · 1 shared paper, 2026 · strength 0.30
  10. Francesco Giovinazzo · 1 shared paper, 2024 · strength 0.22
  11. Hayden Pearce · 1 shared paper, 2024 · strength 0.22
  12. Oonagh M. Griffin · 1 shared paper, 2023 · strength 0.20
  13. Nigel Balfour Jamieson · 2 shared papers, 2021 · strength 0.20
  14. Nicola E. Annels · 1 shared paper, 2024 · strength 0.17
  15. Tarak Agrebi Moumni Chouari · 1 shared paper, 2024 · strength 0.17
  16. Dongmei Deng · 1 shared paper, 2024 · strength 0.17
  17. Elisa Giovannetti · 1 shared paper, 2024 · strength 0.17
  18. Eirini G. Velliou · 1 shared paper, 2024 · strength 0.17
  19. Lois A. Daamen · 1 shared paper, 2021 · strength 0.12
  20. Ángela Lamarca Lete · 1 shared paper, 2021 · strength 0.12
  21. Izaak Quintus Molenaar · 1 shared paper, 2021 · strength 0.12
  22. Rupaly Pandé · 1 shared paper, 2021 · strength 0.12
  23. Hjalmar C. van Santvoort · 1 shared paper, 2021 · strength 0.12
  24. Juan W. Valle · 1 shared paper, 2021 · strength 0.12
  25. Iain Stephen Tait · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.